Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jee Hee Yoo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Diabetes/Metabolism Research and Reviews|June 11, 2020
Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adultsJee Hee Yoo, Sung Woon Park, Ji Eun Jun, et al.
Clinical Endocrinology|May 3, 2019
The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjectsJee Hee Yoo, Yu Mi Kang, Yun Kyung Cho, et al.
Scientific Reports|April 3, 2020
Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal studyJee Hee Yoo, Gyuri Kim, Sung Woon Park, et al.
Diabetes & Metabolism Journal|February 1, 2021
Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without NephropathyMin Sun Choi, Ji Eun Jun, Sung Woon Park, et al.
Scientific Reports|August 15, 2018
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcificationYun Kyung Cho, Yu Mi Kang, Jee Hee Yoo, et al.
Endocrinology and Metabolism (Seoul, Korea)|August 11, 2021
Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary AldosteronismYe Seul Yang, Seung Hun Lee, Jung Hee Kim, et al.
Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.
Endocrinology and Metabolism (Seoul, Korea)|December 14, 2025
Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial ProtocolJi Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, et al.
Diabetologia|April 18, 2024
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trialJi Yoon Kim, Sang-Man Jin, Eun Seok Kang, et al.
Therapeutic Advances in Endocrinology and Metabolism|February 26, 2021
Primary aldosteronism subtyping in the setting of partially successful adrenal vein samplingSeung-Eun Lee, Sung Woon Park, Min Sun Choi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Diabetes/Metabolism Research and Reviews|June 11, 2020
Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adultsJee Hee Yoo, Sung Woon Park, Ji Eun Jun, et al.
Clinical Endocrinology|May 3, 2019
The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjectsJee Hee Yoo, Yu Mi Kang, Yun Kyung Cho, et al.
Scientific Reports|April 3, 2020
Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal studyJee Hee Yoo, Gyuri Kim, Sung Woon Park, et al.
Diabetes & Metabolism Journal|February 1, 2021
Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without NephropathyMin Sun Choi, Ji Eun Jun, Sung Woon Park, et al.
Scientific Reports|August 15, 2018
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcificationYun Kyung Cho, Yu Mi Kang, Jee Hee Yoo, et al.
Endocrinology and Metabolism (Seoul, Korea)|August 11, 2021
Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary AldosteronismYe Seul Yang, Seung Hun Lee, Jung Hee Kim, et al.
Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.
Endocrinology and Metabolism (Seoul, Korea)|December 14, 2025
Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial ProtocolJi Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, et al.
Diabetologia|April 18, 2024
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trialJi Yoon Kim, Sang-Man Jin, Eun Seok Kang, et al.
Therapeutic Advances in Endocrinology and Metabolism|February 26, 2021
Primary aldosteronism subtyping in the setting of partially successful adrenal vein samplingSeung-Eun Lee, Sung Woon Park, Min Sun Choi, et al.
Pageof 3